Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

756 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical and Laboratory Follow-up After Hospitalization for COVID-19 at an Italian Tertiary Care Center.
Spinicci M, Vellere I, Graziani L, Tilli M, Borchi B, Mencarini J, Campolmi I, Gori L, Rasero L, Fattirolli F, Olivotto I, Lavorini F, Marchionni N, Zammarchi L, Bartoloni A; Careggi Post-acute COVID-19 Study Group. Spinicci M, et al. Among authors: olivotto i. Open Forum Infect Dis. 2021 Feb 4;8(3):ofab049. doi: 10.1093/ofid/ofab049. eCollection 2021 Mar. Open Forum Infect Dis. 2021. PMID: 34109256 Free PMC article.
Chagas disease as a cause of heart failure and ventricular arrhythmias in patients long removed from endemic areas: an emerging problem in Europe.
Vannucchi V, Tomberli B, Zammarchi L, Fornaro A, Castelli G, Pieralli F, Berni A, Yacoub S, Bartoloni A, Olivotto I. Vannucchi V, et al. Among authors: olivotto i. J Cardiovasc Med (Hagerstown). 2015 Dec;16(12):817-23. doi: 10.2459/JCM.0000000000000045. J Cardiovasc Med (Hagerstown). 2015. PMID: 25022923 Review.
Timing of invasive septal reduction therapies and outcome of patients with obstructive hypertrophic cardiomyopathy.
Cavigli L, Fumagalli C, Maurizi N, Rossi A, Arretini A, Targetti M, Passantino S, Girolami F, Tomberli B, Baldini K, Tomberli A, Antoniucci D, Yacoub MH, Marchionni N, Stefano PL, Cecchi F, Olivotto I. Cavigli L, et al. Among authors: olivotto i. Int J Cardiol. 2018 Dec 15;273:155-161. doi: 10.1016/j.ijcard.2018.09.004. Epub 2018 Sep 5. Int J Cardiol. 2018. PMID: 30213605
Prevalence of cardiac amyloidosis among adult patients referred to tertiary centres with an initial diagnosis of hypertrophic cardiomyopathy.
Maurizi N, Rella V, Fumagalli C, Salerno S, Castelletti S, Dagradi F, Torchio M, Marceca A, Meda M, Gasparini M, Boschi B, Girolami F, Parati G, Olivotto I, Crotti L, Cecchi F. Maurizi N, et al. Among authors: olivotto i. Int J Cardiol. 2020 Feb 1;300:191-195. doi: 10.1016/j.ijcard.2019.07.051. Epub 2019 Jul 17. Int J Cardiol. 2020. PMID: 31371117
Association of Obesity With Adverse Long-term Outcomes in Hypertrophic Cardiomyopathy.
Fumagalli C, Maurizi N, Day SM, Ashley EA, Michels M, Colan SD, Jacoby D, Marchionni N, Vincent-Tompkins J, Ho CY, Olivotto I; SHARE Investigators. Fumagalli C, et al. Among authors: olivotto i. JAMA Cardiol. 2020 Jan 1;5(1):65-72. doi: 10.1001/jamacardio.2019.4268. JAMA Cardiol. 2020. PMID: 31693057 Free PMC article.
Sex-related differences in exercise performance and outcome of patients with hypertrophic cardiomyopathy.
Ghiselli L, Marchi A, Fumagalli C, Maurizi N, Oddo A, Pieri F, Girolami F, Rowin E, Mazzarotto F, Cicoira M, Ribichini F, Arretini A, Targetti M, Passantino S, Cecchi F, Marchionni N, Maron M, Mori F, Olivotto I. Ghiselli L, et al. Among authors: olivotto i. Eur J Prev Cardiol. 2020 Nov;27(17):1821-1831. doi: 10.1177/2047487319886961. Epub 2019 Nov 7. Eur J Prev Cardiol. 2020. PMID: 31698967
Targeted Medical Therapies for Hypertrophic Cardiomyopathy.
Fumagalli C, De Gregorio MG, Zampieri M, Fedele E, Tomberli A, Chiriatti C, Marchi A, Olivotto I. Fumagalli C, et al. Among authors: olivotto i. Curr Cardiol Rep. 2020 Jan 28;22(2):10. doi: 10.1007/s11886-020-1258-x. Curr Cardiol Rep. 2020. PMID: 31993794 Review.
756 results